MRM Health NV announced that it has received €14,250,000 in an equity round of funding on February 19, 2020. The transaction will include participation from new investor DuPont Nutrition & Biosciences through DuPont de Nemours, Inc., Qbic II, a fund managed by QBIC Venture Partners, and VIB BV., and returning investors, Ackermans & Van Haaren NV for €4,000,000 and more than 15% stake, and MRM Technologies.